Alendronate in combination with calcium and vitamin D prevents bone loss after orthotopic liver transplantation: A prospective single-center study
Open Access
- 20 July 2005
- journal article
- clinical trial
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 11 (8) , 960-966
Abstract
Bone loss is a common complication in patients before and after liver transplantation (LT). The aim of this study was to investigate the efficacy of prophylactic treatment with bisphosphonates after LT in preventing progressive bone loss in LT patients. We included 136 patients with end-stage liver diseases awaiting LT. Bone mineral density (BMD) (by dual X-ray absorptiometry) and markers of bone metabolism were determined before, and 4, 12, 24, 36, and 48 months after LT. All patients received vitamin D and calcium supplementation before and after LT, those with osteopenia or osteoporosis prior to LT were additionally treated with alendronate following LT. Decreased BMD was seen in a high percentage of patients undergoing LT (osteopenia 48.5%, osteoporosis 23.5%). Reduced BMD before LT was not related to gender, underlying liver disease, or Child-Turcotte-Pugh classification. Body mass index (BMI) prior to LT, however, correlated significantly with the fracture risk. Alendronate prevented the ubiquitously observed bone loss after LT in patients with osteoporosis and osteopenia and, in addition, led to an increase in BMD in patients with osteoporosis within 24 months after LT. In conclusion, our study suggests that alendronate is efficacious in preventing the natural course of bone loss associated with LT. (Liver Transpl 2005;11:960–966.)Keywords
This publication has 52 references indexed in Scilit:
- Immunosuppressive and postoperative effects of orthotopic liver transplantation on bone metabolismLiver Transplantation, 2004
- Osteopenia and osteoporosis in patients with end-stage liver disease caused by hepatitis C and alcoholic liver disease: Not just a cholestatic problemLiver Transplantation, 2003
- Serial measurements of bone density at the lumbar spine do not predict fracture risk after liver transplantationLiver Transplantation, 2003
- Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up studyThe Lancet, 2001
- Evidence of continuing bone recovery at a mean of 7 years after liver transplantationLiver Transplantation and Surgery, 1999
- Predicting bone loss following orthotopic liver transplantationGut, 1999
- Bone disease in patients with primary sclerosing cholangitis: prevalence, severity and prediction of progressionJournal of Hepatology, 1998
- CalcitriolDrugs & Aging, 1994
- Bone disease after orthotopic liver transplantationJournal of Hepatology, 1988
- Metabolic Bone Disease in Alcoholic Cirrhosis: A Comparison of the Effect of Vitamin D2 25-Hydroxyvitamin D, or Supportive TreatmentHepatology, 1984